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Adenovirus infection subverts nucleolar structure and function. B23 is a nucleolar protein present
in two isoforms (B23.1 and B23.2) and both isoforms have been identified as stimulatory factors
for adenovirus DNA replication. Here, it is demonstrated that the two isoforms of B23, B23.1
and B23.2, interact and co-localize differently with viral DNA replication proteins pTP and DBP in
adenovirus-infected cells. Thus, the mechanism by which the two proteins stimulate viral DNA
replication is likely to differ. These data also demonstrate the importance of testing both isoforms
of B23 for interactions with viral proteins and nucleic acids.
Nucleolar protein B23 exists as two isoforms that are
present in similar amounts, differing only at their carboxy
termini (Chang & Olson, 1989; Wang et al., 1993). B23.1 is
294 aa long and is known to participate in the infectious
cycle of diverse viruses, including adenovirus (Okuwaki
et al., 2001), adeno-associated virus (Bevington et al.,
2007), human immunodeficiency virus type 1 (Fankhauser
et al., 1991; Flint & Shenk, 1997), hepatitis C virus (Mai
et al., 2006) and Japanese encephalitis virus (Tsuda et al.,
2006). In contrast, B23.2 is 259 aa long, sharing the first
257 aa with B23.1, and is derived by differential splicing. Its
role in the replication of any virus other than adenovirus
has not been examined.
The icosahedral adenovirus particle contains a double-
stranded DNA genome approximately 36 kbp in size.
Replication in the cell nucleus results in nucleolar
disruption (Castiglia & Flint, 1983) and redistribution of
nucleolar antigens, including B23.1 (Lutz et al., 1996;
Matthews, 2001; Walton et al., 1989) and upstream binding
factor (UBF) (Lawrence et al., 2006). Previous research
showed that B23.1 and B23.2 stimulate adenovirus DNA
replication independently (Okuwaki et al., 2001) and
concluded that the two proteins are essentially equivalent
in their activities, perhaps acting as molecular chaperones.
Three viral proteins are central to adenovirus DNA
replication: the viral polymerase (Adpol), preterminal
protein (pTP), which primes DNA synthesis (Liu et al.,
2003), and DNA-binding protein (DBP), which binds
single-stranded DNA displaced during genome replication
and is required for initiation and elongation of replication
(de Jong et al., 2003b). During infection, a virally encoded
protease cleaves pTP (653 aa) to produce mature TP via an
intermediate known as iTP, eventually removing 350 aa
from the N terminus (Webster et al., 1994).
Here, we show that B23.1 interacts with both pTP and
DBP, whereas B23.2 interacts with DBP only in in vitro
pull-down assays. Early in infection, DBP accumulates in
discrete areas in the nucleus and recruits B23.2 only. Later,
pTP becomes detectable in separate centres adjacent to
DBP. At this stage, both B23.1 and B23.2 are recruited to
the pTP-rich centres only.
A pull-down assay was used to identify adenovirus DNA
replication proteins that interact with human B23.1 and
B23.2. Both sequences were amplified from pGFP-B23
(Chen & Huang, 2001), inserted into pRSETA (Invitrogen)
and expressed with an N-terminal His6 tag. Constructs
were transformed into BL21-Gold (DE3) pLysS competent
Escherichia coli and, following induction with 0.1 mM
IPTG, proteins were purified by using Ni–NTA agarose
(Qiagen) and eluted with 250 mM imidazole. Purified
proteins were coupled onto CNBr-activated Sepharose
(Sigma) following the manufacturer’s instructions.
Approximately 10
7 HeLa cells were infected with human
adenovirus serotype 2 (Ad2) at an m.o.i. of 5. At 18 h post-
infection, duplicate cell extracts were prepared by sonica-
tion of the cells in PBS/1% NP-40 (v/v) and passed over
equivalent amounts (50 mg) of immobilized B23.1 or
B23.2. Following PBS washes, bound proteins were eluted
in 26 SDS-PAGE loading buffer and subjected to Western
blotting with antibodies against the viral replication
proteins pTP [mouse 3D11 (Webster et al., 1997); Fig. 1a]
and DBP (a kind gift of Professor W. Russell, University of
St Andrews, UK; Fig. 1b). We found that B23.1 (but not
B23.2) interacted with pTP; there was reduced interaction
with iTP and essentially none with TP in this experiment.
Relative to iTP and TP, pTP has a higher affinity for viral
DNA and it has been proposed that pTP helps to stabilize
the interaction between the viral polymerase and partially
unwound viral DNA at the origin (de Jong et al., 2003a). As
pTP interacts with viral DNA at the origins of replication,
this may indicate a direct stimulatory role for B23.1 at this
step in viral DNA replication (de Jong et al., 2003a, b;
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but neither isoform bound Adpol (data not shown). For a
reverse pull-down, pTP and DBP were baculovirus-
expressed and purified as described previously
(Monaghan et al., 1994; Temperley & Hay, 1992), then
immobilized on Sepharose columns. The columns were
used to bind proteins from uninfected cell lysates and the
bound proteins were probed in a Western blot with anti-
B23.1 (Zymed) or anti-B23 (Santa Cruz), which detects
both isoforms. In the absence of other viral proteins and/or
DNA, B23.1 associated with pTP, but not DBP (Fig. 1c).
We saw no association of DBP with B23.1 or B23.2 (data
not shown), indicating that this interaction may be
dependent upon additional viral factors. Fig. 1(d) shows
a Coomassie stain of the purified B23.1 and B23.2 used in
these experiments. Confirmation that the interaction
between B23.1 and pTP was direct was gained by means
of an immunoprecipitation assay in which anti-B23.1 and
anti-pTP antibodies, in combination with protein G–
agarose (Sigma), both precipitated B23.1 from a mixture
containing only recombinant B23.1 and pTP (Fig. 1e).
However, when pTP was omitted from the mixture, the
anti-pTP antibody did not precipitate B23.1.
We then compared the localization of B23.1 and B23.2 with
that of pTP and DBP in infected cells. As there is no B23.2-
specific antibody, the localization of B23.1 and B23.2 was
examined by using constructs encoding B23.1 and B23.2
tagged N-terminally with either enhanced green fluorescent
protein (EGFP) or Myc. HeLa cells (grown on glass
coverslips in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum) were either transfected
with 1 mg plasmid DNA by using Lipofectamine 2000
(Invitrogen) and infected with Ad2 at an m.o.i. of 5, or
were infected only. The localization of B23.1, B23.2, pTP
and DBP was then examined by immunofluorescence at
18 h post-infection.
Examining B23.2 first, we saw that EGFP–B23.2 was
localized mainly in the nucleolus of uninfected cells, as
indicated by the nucleolar antigen nucleolin (Fig. 2a). As
adenovirus infection began and significant levels of DBP
accumulated, we saw movement of some EGFP–B23.2
from the nucleolus into DBP-rich centres (Fig. 2b). Fig. 2(c)
shows two infected cells transfected with EGFP–B23.2, the
one on the left expressing pTP and DBP and the one on the
right expressing DBP only. The left-hand cell represents a
later stage in the infection, when there is a greater number
of smaller DBP-rich centres alongside newly formed pTP-
rich centres. This is typical of the timing of the detection of
these antigens in an adenovirus infection when a wider
range of times are examined (i.e. DBP detection prior to
pTP detection; data not shown) and illustrative that these
infections are asynchronous. We saw that, in cells lacking
detectable pTP, EGFP–B23.2 colocalized with DBP.
However, when cells expressed both DBP and pTP,
EGFP–B23.2 co-localized exclusively with pTP adjacent to
the DBP-rich centres.
Moving on to B23.1, a proportion of EGFP–B23.1 moved
from a nucleolar location in uninfected cells (Fig. 2d) to
Fig. 1. (a, b) Ad2-infected HeLa cell lysates
were passed over B23.1-, B23.2- or BSA-
conjugated Sepharose beads. Proteins bound
to the beads were subjected to SDS-PAGE
and probed by Western blot for pTP (a) and
DBP (b). (c) DBP-, pTP- and BSA-conjugated
beads were also used to bind proteins from
uninfected HeLa cells and probed for B23.1. In
(a–c), BSA-conjugated Sepharose acted as a
negative control for non-specific binding. (d)
Purified, His-tagged B23.1 and B23.2 were
analysed by SDS-PAGE and Coomassie stain
for total protein content. (e) A mixture of B23.1
and pTP were immunoprecipitated by using
antibodies to either B23.1 or pTP and the
proteins pulled down were probed by Western
blot for B23.1. In the control, a sample of
B23.1 only was immunoprecipitated by using
antibody to pTP. Sizes of molecular mass
markers (in kDa) are shown.
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with pTP within the nucleoplasm [Fig. 2e(i)]. The
movement of B23.1 from the nucleolus into the nucleo-
plasm only occurred once pTP was expressed and was not
seen in the presence of DBP only (compare left-hand cell
with right-hand cell). The same was also seen with Myc-
tagged B23.1 (data not shown) and supported the pull-









Fig. 2. Subcellular location of EGFP–B23.2,
EGFP–B23.1, endogenous B23.1, pTP and
DBP in uninfected and adenovirus-infected
cells. In all images, viral proteins are detected
by relevant antiserum. (a) EGFP–B23.2
(green) and nucleolin (a marker for the nucle-
olus; red) in uninfected cells. (b) EGFP–B23.2
and DBP (red) in adenovirus-infected cells. (c)
EGFP–B23.2 (green), pTP (red) and DBP
(blue) in adenovirus-infected cells. Note that
two cells transfected with EGFP–B23.2 are
shown, one expressing both DBP and pTP and
the other expressing DBP only. Insets: (i)
close-up of the region boxed in the left-hand
cell; (ii) close-up of the region boxed in the
right-hand cell. (d) EGFP–B23.1 (green) and
nucleolin (red) in uninfected cells. (e) Cells
transfected with EGFP–B23.1 and infected
with Ad2. pTP is shown in red and DBP in
blue. Insets: (i) close-up of the region boxed in
the left-hand cell; (ii) close-up of the region
boxed in the right-hand cell. (f) Endogenous
B23.1 (red) and DBP (green) in infected cells.
(g) Cell transfected with both EGFP–B23.2
plus Myc–B23.1 (red) and infected with
adenovirus. (h) EGFP–B23.2 expression in
an infected cell, showing endogenous B23.1
(red) and DBP (blue). (j) EGFP–B23.2 expres-
sion in an infected cell, showing extranucleolar
endogenous B23.1 (red) and DBP (blue). All
images were taken by using a Leica confocal
microscope with a 63 oil immersion lens at
the University of Bristol MRC Cell Imaging
Facility, Bristol, UK, and are of a single focal
plane approximately 0.3 mm deep; bars,
10 mm.
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infected cells (Matthews, 2001), and Okuwaki et al. (2001)
suggested some co-localization of haemagglutinin-tagged
B23.1 with DBP in infected cells. We found that
endogenous B23.1 occupied locations adjacent to DBP
within the nucleoplasm, with only minor overlap (Fig. 2f).
The sequestration of some B23.1 into the nucleoplasm
corresponded with the development of a large number of
smaller DBP-rich centres [compare the two cells in
Fig. 2(f)]. Indeed, in contrast to B23.2, we only observed
B23.1 outside the infected-cell nucleolus once pTP
expression was detectable (Fig. 2e).
As endogenous levels of B23.1 and B23.2 are similar in
normal cells, we also examined cells in which both Myc–
B23.1 and EGFP–B23.2 were overexpressed. In infected
cells, the sequestration of EGFP–B23.2 into extranucleolar
sites reminiscent of DBP was unaffected by co-expression
with Myc–B23.1 (Fig. 2g).
We also noted that initial co-localization of EGFP–B23.2
with DBP occurred independently of endogenous B23.1,
which was still nucleolar at this time (Fig. 2h). However,
once endogenous B23.1 was detected outside the nucleolus,
EGFP–B23.2 and endogenous B23.1 both co-localized in
centres distinct from DBP (Fig. 2j).
Based on our finding that B23.2 interacts only with DBP
from virally infected cells in pull-down assays, we propose
that B23.2 is initially sequestered into DBP/viral DNA-rich
centres prior to detectable pTP expression. Once pTP
expression becomes detectable, B23.1 can be detected in
pTP-rich centres, due to direct interaction with pTP. B23.2
is then drawn into the pTP-rich centres by interaction with
the pTP–B23.1–viral DNA complex. Both isoforms have
been shown, using in vitro assays, to stimulate viral DNA
replication independently (Lawrence et al., 2006; Okuwaki
et al., 2001); our data indicate that the two isoforms of B23
operate in two distinct replicative environments. The first
is B23.2- and DBP-rich, giving way to a second
environment rich in pTP, B23.1 and B23.2.
Okuwaki et al. (2001) presented data showing that the first
160 aa of B23 stimulated adenovirus replication in vitro.
We investigated this mutant’s ability to interact with pTP

























Fig. 3. (a, b) Western blot for (a) pTP and (b)
DBP following depletion of Ad2-infected cell
lysates by B23.1, B23.2, B23 1–160 and
BSA. (c) Myc–B23 1–160 and pTP in infected
cells. Image was taken by using a Leica
confocal microscope with a 63 oil immersion
lens and is of a single focal plane approxi-
mately 0.3 mm deep; bar, 10 mm. (d) Purified
B23 1–160 was analysed by SDS-PAGE and
Coomassie stain for quality. (e) Schematic
diagram illustrating the binding and co-local-
ization properties of B23.1, B23.2, B23 1–
160 and B23 1–116 in infected cells. Note
that the last 2 aa of B23.2 are not equivalent to
sequences in B23.1. In the case of B23.1 and
B23.2, the co-localization is confirmed by
EGFP- and Myc-tagged fusion proteins. For
B23 1–160, the localization was shown by
Myc-tagged fusion protein only and, for B23
1–116, the co-localization was shown by
EGFP-tagged fusion protein only.
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Whilst we were unable to clone EGFP–B23 1–160, we were
able to generate a Myc-tagged version that also co-localized
only with pTP in infected cells (Fig. 3c). A smaller mutant,
1–116 (which does not stimulate viral DNA replication),
was expressed with an N-terminal EGFP tag and it too co-
localized only with pTP (data not shown). This implies that
the interaction of B23.1 with pTP can be separated from
the stimulation of DNA replication. A Coomassie stain of
the purified B23 1–160 can be seen in Fig. 3(d).
Whilst B23.2 contains the required sequences to pull down
pTP from infected cells, no interaction was detected,
suggesting that the conformation of B23.2 specifically
prevents interaction with pTP. Our findings are summar-
ized in Fig. 3(e).
Although B23.1 and B23.2 form multimeric complexes, we
have separated the two proteins in situ in infected cells,
reflecting the dynamic interaction between the two
(Okuwaki et al., 2002). However, further conclusions about
B23.2 are hampered by the lack of published information on
its functions in the cell and the lack of a specific antibody.
B23.1 and B23.2 affect replication of adenovirus genomes
in different assays (Lawrence et al., 2006; Okuwaki et al.,
2001). Our data show that these effects are mediated
primarily through interactions with pTP and DBP, that
B23.1 and B23.2 act in different replicative environments as
the infection progresses and that the two isoforms have
different interactions with the replicative machinery.
Three nucleolar antigens are now known to associate with
the adenovirus DNA replication machinery: B23.1, B23.2
and UBF (Lawrence et al., 2006). This report expands the
conclusion that the nucleolus is a source of cellular co-
factors for adenoviral replication and underlines the
significance of B23.2 when examining the role of the
nucleolus in viral replication.
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